These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 32427557)

  • 41. Breast tomosynthesis for the clarification of mammographic BI-RADS 3 lesions can decrease follow-up examinations and enables immediate cancer diagnosis.
    Bahrs SD; Otto V; Hattermann V; Klumpp B; Hahn M; Nikolaou K; Siegmann-Luz K
    Acta Radiol; 2018 Oct; 59(10):1176-1183. PubMed ID: 29451022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of the Interaction Between Mammographic Breast Density, Body Mass Index, and Menopausal Status With Breast Cancer Risk Among Korean Women.
    Tran TXM; Moon SG; Kim S; Park B
    JAMA Netw Open; 2021 Dec; 4(12):e2139161. PubMed ID: 34940866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk of malignancy in palpable solid breast masses considered probably benign or low suspicion: implications for management.
    Giess CS; Smeglin LZ; Meyer JE; Ritner JA; Birdwell RL
    J Ultrasound Med; 2012 Dec; 31(12):1943-9. PubMed ID: 23197547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Chiraiya project: a retrospective analysis of breast cancer detection gaps addressed via mobile mammography in Jammu Province, India.
    Gupta G; Jamwal N; Gupta R
    BMC Public Health; 2024 Aug; 24(1):2087. PubMed ID: 39090665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Computer-Aided Diagnosis in Multiparametric Magnetic Resonance Imaging Screening of Women With Extremely Dense Breasts to Reduce False-Positive Diagnoses.
    Verburg E; van Gils CH; Bakker MF; Viergever MA; Pijnappel RM; Veldhuis WB; Gilhuijs KGA
    Invest Radiol; 2020 Jul; 55(7):438-444. PubMed ID: 32149858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequency and Cancer Yield of BI-RADS Category 3 Lesions Detected at High-Risk Screening Breast MRI.
    Edmonds CE; Lamb LR; Mercaldo SF; Sippo DA; Burk KS; Lehman CD
    AJR Am J Roentgenol; 2020 Feb; 214(2):240-248. PubMed ID: 31799867
    [No Abstract]   [Full Text] [Related]  

  • 47. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison between short-interval and regular-interval follow-up for BI-RADS category 3 lesions.
    Ruamsup S; Wiratkapun C; Wibulpolprasert B; Lertsithichai P
    Singapore Med J; 2010 Feb; 51(2):120-5. PubMed ID: 20358150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breast ultrasound diagnostic performance and outcomes for mass lesions using Breast Imaging Reporting and Data System category 0 mammogram.
    Zanello PA; Robim AF; Oliveira TM; Elias Junior J; Andrade JM; Monteiro CR; Sarmento Filho JM; Carrara HH; Muglia VF
    Clinics (Sao Paulo); 2011; 66(3):443-8. PubMed ID: 21552670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk.
    Kerlikowske K; Ichikawa L; Miglioretti DL; Buist DS; Vacek PM; Smith-Bindman R; Yankaskas B; Carney PA; Ballard-Barbash R;
    J Natl Cancer Inst; 2007 Mar; 99(5):386-95. PubMed ID: 17341730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Outcomes of Mammographic BI-RADS 3 Lesions in the Community Hospital Setting.
    Friedman P; Kerwin L; Chung J
    Can Assoc Radiol J; 2016 Nov; 67(4):313-317. PubMed ID: 27523446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness of assigning BI-RADS category-3 to breast lesion with respect to follow-up.
    Masroor I
    J Coll Physicians Surg Pak; 2008 Apr; 18(4):209-12. PubMed ID: 18474152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Deep Learning Decision Support Tool to Improve Risk Stratification and Reduce Unnecessary Biopsies in BI-RADS 4 Mammograms.
    Ezeana CF; He T; Patel TA; Kaklamani V; Elmi M; Brigmon E; Otto PM; Kist KA; Speck H; Wang L; Ensor J; Shih YT; Kim B; Pan IW; Cohen AL; Kelley K; Spak D; Yang WT; Chang JC; Wong STC
    Radiol Artif Intell; 2023 Nov; 5(6):e220259. PubMed ID: 38074778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Using the BI-RADS lexicon in a restrictive form of double reading as a strategy for minimizing screening mammography recall rates.
    Ghate SV; Baker JA; Kim CE; Johnson KS; Walsh R; Soo MS
    AJR Am J Roentgenol; 2012 Apr; 198(4):962-70. PubMed ID: 22451567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparative efficacy study of diagnostic digital breast tomosynthesis and digital mammography in BI-RADS 4 breast cancer diagnosis.
    Ezeana CF; Puppala M; Wang L; Chang JC; Wong STC
    Eur J Radiol; 2022 Aug; 153():110361. PubMed ID: 35617870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment and Management of Challenging BI-RADS Category 3 Mammographic Lesions.
    Michaels AY; Birdwell RL; Chung CS; Frost EP; Giess CS
    Radiographics; 2016; 36(5):1261-72. PubMed ID: 27541437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiomics Based on Adapted Diffusion Kurtosis Imaging Helps to Clarify Most Mammographic Findings Suspicious for Cancer.
    Bickelhaupt S; Jaeger PF; Laun FB; Lederer W; Daniel H; Kuder TA; Wuesthof L; Paech D; Bonekamp D; Radbruch A; Delorme S; Schlemmer HP; Steudle FH; Maier-Hein KH
    Radiology; 2018 Jun; 287(3):761-770. PubMed ID: 29461172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Impact of Mammographic, Radiologist, and Patient Factors on the Likelihood of Probably Benign (BI-RADS 3) Assessment at Diagnostic Mammography.
    Chesebro AL; Abbasi N; Lacson R; Chikarmane SA; Licaros ARL; Giess CS
    J Breast Imaging; 2024 May; 6(3):246-253. PubMed ID: 38655858
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of Breast Imaging Reporting and Data System Category 3 mammograms and the use of stereotactic vacuum-assisted breast biopsy in a nonacademic community practice.
    Mendez A; Cabanillas F; Echenique M; Malekshamran K; Perez I; Ramos E
    Cancer; 2004 Feb; 100(4):710-4. PubMed ID: 14770425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction for Breast Cancer in BI-RADS Category 4 Lesion Categorized by Age and Breast Composition of Women in Songklanagarind Hospital.
    Noonpradej S; Wangkulangkul P; Woodtichartpreecha P; Laohawiriyakamol S
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):531-536. PubMed ID: 33639670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.